Evidence map›Paper›PMID 29568978›Full record

ArticleParasitology research2018

Apoptotic impact on Brugia malayi by sulphonamido-quinoxaline: search for a novel therapeutic rationale.

Priyanka S Bhoj, Rahul G Ingle, Kalyan Goswami, Lingaraj Jena, Shailesh Wadher

Abstract read
PubMed Publisher
In one paragraph

Article in Parasitology research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Priyanka S BhojDepartment of Biochemistry, Mahatma Gandhi Institute of Medical Sciences, Sevagram, Wardha, Maharashtra, 442102, India.
Rahul G IngleSchool of Pharmacy, S.R.T.M. University, Nanded, Maharashtra, 436306, India.
Kalyan GoswamiDepartment of Biochemistry, Mahatma Gandhi Institute of Medical Sciences, Sevagram, Wardha, Maharashtra, 442102, India. goswamikln@gmail.com.ORCID http://orcid.org/0000-0002-5052-0675
Lingaraj JenaDepartment of Biochemistry, Mahatma Gandhi Institute of Medical Sciences, Sevagram, Wardha, Maharashtra, 442102, India.
Shailesh WadherSchool of Pharmacy, S.R.T.M. University, Nanded, Maharashtra, 436306, India.
Mahatma Gandhi Institute of Medical Sciences · INSwami Ramanand Teerth Marathwada University · IN

Funding

Department of Biotechnology , Ministry of Science and Technology BT/PR/4988/INF/22/155/2012DST-FIST (IN) SR/FST/LSI-470/2010
6 · The paper itself

Abstract

Human lymphatic filariasis although not fatal but poses serious socioeconomic burden due to associated disability. This is reflected by the huge magnitude of the estimated disability-adjusted life years of about 5.09 million. Therefore, following WHO mandate, our earlier studies on antifilarial drug development revealed the significance of apoptosis. Apoptotic impact has been implicated in anticancer rationale of several drugs. In this study, we explored the antifilarial potential of sulphonamido-quinoxaline compounds, shown to be specific inhibitor for c-Met kinase in human cancer cells. Out of studied compounds, Q4, showing favorable drug-likeness and medicinal chemistry properties on bioinformatics platform along with subsequently recorded lowest IC

Indexed as

AnimalsAnthelminticsApoptosisBrugia malayiElephantiasis, FilarialHumansParasitic Sensitivity TestsQuinoxalinesSulfonamidesAnthelminticsQuinoxalinesSulfonamidesApoptosisBrugia malayic-Met kinaseLymphatic filariasisQuinoxaline

Identifiers

PMID29568978
OpenAlexW2796052418

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.